company background image
ERIS logo

Eris Lifesciences NSEI:ERIS Rapport sur les actions

Dernier prix

₹1.21k

Capitalisation boursière

₹164.6b

7D

0.8%

1Y

43.3%

Mise à jour

20 Aug, 2024

Données

Finances de l'entreprise +

Eris Lifesciences Limited

NSEI:ERIS Rapport sur les actions

Capitalisation boursière : ₹164.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

ERIS Aperçu des actions

Eris Lifesciences Limited, avec ses filiales, fabrique, commercialise et distribue des formulations de marque nationale pour les thérapies chroniques et subchroniques en Inde.

ERIS analyse fondamentale
Score flocon de neige
Évaluation2/6
Croissance future4/6
Performances passées2/6
Santé financière2/6
Dividendes2/6

Eris Lifesciences Limited Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Eris Lifesciences
Historique des cours de bourse
Prix actuel de l'action₹1,209.70
Plus haut sur 52 semaines₹1,225.00
Plus bas sur 52 semaines₹792.35
Bêta0.36
1Variation sur 1 mois20.21%
Variation sur 3 mois33.27%
Variation sur 1 an43.32%
3Variation sur 3 ans65.66%
Variation sur 5 ans218.97%
Évolution depuis l'introduction en bourse101.11%

Nouvelles et mises à jour récentes

Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Aug 05
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Aug 04
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Recent updates

Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Aug 05
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Aug 04
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Jul 13
Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

May 24
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

May 10
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Mar 14
An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Feb 15
Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Dec 28
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Dec 07
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Nov 11
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Jul 20
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

Nov 20
Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

Jun 20
These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Feb 24
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Dec 28
Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

Sep 23
Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

May 26
If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 17
Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Mar 12
Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Feb 25
Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Feb 12
Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Jan 30
Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Jan 17
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Dec 30
Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 10
Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year

Nov 23
Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year

Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?

Oct 22
Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?

How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?

Oct 01
How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?

How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?

Sep 14
How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?

Rendement pour les actionnaires

ERISIN PharmaceuticalsIN Marché
7D0.8%0.9%1.0%
1Y43.3%51.7%43.6%

Rendement vs Industrie: ERIS a sous-performé le secteur Indian Pharmaceuticals qui a rapporté 51.7 % au cours de l'année écoulée.

Rendement vs marché: ERIS correspond au marché Indian qui a rapporté 43.6 % au cours de l'année écoulée.

Volatilité des prix

Is ERIS's price volatile compared to industry and market?
ERIS volatility
ERIS Average Weekly Movement4.1%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.8%
10% most volatile stocks in IN Market9.8%
10% least volatile stocks in IN Market4.4%

Cours de l'action stable: Le cours de l'action de ERIS a été volatil au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de ERIS ( 4% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
20073,548Amit Bakshiwww.eris.co.in

Eris Lifesciences Limited, avec ses filiales, fabrique, commercialise et distribue en Inde des préparations de marque nationale pour les thérapies chroniques et subchroniques. L'entreprise propose diverses préparations de marque dans différents domaines thérapeutiques, tels que l'antidiabète, l'anti-infectieux, le sanguin, le cardiovasculaire, la dermatologie, le gastro-intestinal, la gastro-entérologie, l'hématologie, les hormones, le système nerveux central, la neuropsychiatrie, l'otologie, la douleur/analgésie, le respiratoire, la stomatologie, la cosmétologie, la santé de la femme et les vitamines/minéraux/nutriments. Elle fournit également des services de soins aux patients, notamment la mesure de la pression artérielle, la mesure ambulatoire de l'électrocardiogramme, le système de surveillance du glucose en continu, l'étude du sommeil et les solutions de soins prénatals.

Eris Lifesciences Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Eris Lifesciences se comparent-ils à sa capitalisation boursière ?
ERIS statistiques fondamentales
Capitalisation boursière₹164.62b
Bénéfices(TTM)₹3.80b
Recettes(TTM)₹22.47b

43.3x

Ratio P/E

7.3x

Ratio P/S

Le site ERIS est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
ERIS compte de résultat (TTM)
Recettes₹22.47b
Coût des recettes₹4.82b
Marge brute₹17.65b
Autres dépenses₹13.84b
Les revenus₹3.80b

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)27.95
Marge brute78.54%
Marge bénéficiaire nette16.93%
Ratio dettes/capitaux propres86.3%

Quelles ont été les performances à long terme de ERIS?

Voir les performances historiques et les comparaisons

Dividendes

0.6%

Rendement actuel des dividendes

0%

Ratio de distribution